CA2469953C - Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides - Google Patents

Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides Download PDF

Info

Publication number
CA2469953C
CA2469953C CA2469953A CA2469953A CA2469953C CA 2469953 C CA2469953 C CA 2469953C CA 2469953 A CA2469953 A CA 2469953A CA 2469953 A CA2469953 A CA 2469953A CA 2469953 C CA2469953 C CA 2469953C
Authority
CA
Canada
Prior art keywords
substituted
unsubstituted
thiadiazole
sulfonamide
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2469953A
Other languages
English (en)
Other versions
CA2469953A1 (fr
Inventor
James B. Jaquith
Gerald Villeneuve
Alain Boudreault
Stephen Morris
Jon Durkin
John W. Gillard
Kimberly Hewitt
H. Nicholas Marsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmascience Inc
Original Assignee
Pharmascience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002364985A external-priority patent/CA2364985A1/fr
Application filed by Pharmascience Inc filed Critical Pharmascience Inc
Priority to CA2469953A priority Critical patent/CA2469953C/fr
Publication of CA2469953A1 publication Critical patent/CA2469953A1/fr
Application granted granted Critical
Publication of CA2469953C publication Critical patent/CA2469953C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Abstract

La présente invention concerne des composés représentés par la formule (I) et l'utilisation de composés de formule (I) en tant qu'agents neuroprotecteurs dans le traitement des troubles neuronaux des systèmes nerveux central et périphérique.
CA2469953A 2001-12-14 2002-12-16 Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides Expired - Fee Related CA2469953C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2469953A CA2469953C (fr) 2001-12-14 2002-12-16 Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA002364985A CA2364985A1 (fr) 2001-12-14 2001-12-14 Imidazo(2,1-b)thiadiazole-sulfonamides
CA2,364,985 2001-12-14
CA2469953A CA2469953C (fr) 2001-12-14 2002-12-16 Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides
PCT/CA2002/001942 WO2003051890A1 (fr) 2001-12-14 2002-12-16 Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides

Publications (2)

Publication Number Publication Date
CA2469953A1 CA2469953A1 (fr) 2003-06-26
CA2469953C true CA2469953C (fr) 2014-02-25

Family

ID=32870052

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2469953A Expired - Fee Related CA2469953C (fr) 2001-12-14 2002-12-16 Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides

Country Status (1)

Country Link
CA (1) CA2469953C (fr)

Also Published As

Publication number Publication date
CA2469953A1 (fr) 2003-06-26

Similar Documents

Publication Publication Date Title
US7700635B2 (en) Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
EP2411395B1 (fr) Dérivés de furopyrimidinedione à titre de modulateurs de trpa1
CA2873341C (fr) Derives de benzimidazole-proline
TW201307342A (zh) ２－芳基咪唑并［１，２－ｂ］嗒□．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡□衍生物
EP2626360A1 (fr) Procédé pour la préparation de pyrimidinone fusionné utiles en tant que modulateurs de TRPV3
CN101506199A (zh) 用作食欲素受体拮抗剂的氮杂环丁烷化合物
CN101730696A (zh) 3-氮杂-二环[3.3.0]辛烷化合物
JP2010522191A (ja) Ｍａｐｋ／ｅｒｋキナーゼ阻害剤
EP1324993A2 (fr) Thiazepine-1,4 substituee et analogues de celle-ci activateurs de caspases et inducteurs d'apoptose, et utilisation
JP2000512641A (ja) １，２，４―ベンゾチアジアジン誘導体、その製造および使用
EP3740493B1 (fr) Inhibteurs de l'indoléamine 2,3-dioxygénase et/ou du tryptophane dioxygénase
US20060135571A1 (en) Imidazo(2,1-b)-1,3,4-thiadiazole sulfoxides and sulfones
CA2469953C (fr) Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides
EP1636242A1 (fr) Imidazo (2,1-b)-1,3,4,-thiadiazole-2-sulfonamides acyles et non acyles, et utilisations associees
US20060234987A1 (en) Neuroprotective benzo 1 3 oxathiol 2 ones
CN114667143A (zh) 用于预防或抑制轴突变性的组合物

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20181217